Logo image of CLE.MI

CLASS EDITORI SPA (CLE.MI) Stock Fundamental Analysis

BIT:CLE - Euronext Milan - IT0005117848 - Common Stock - Currency: EUR

0.096  0 (-1.64%)

Fundamental Rating

2

Taking everything into account, CLE scores 2 out of 10 in our fundamental rating. CLE was compared to 65 industry peers in the Media industry. While CLE is still in line with the averages on profitability rating, there are concerns on its financial health. CLE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CLE has reported negative net income.
In the past year CLE had a positive cash flow from operations.
In multiple years CLE reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CLE reported negative operating cash flow in multiple years.
CLE.MI Yearly Net Income VS EBIT VS OCF VS FCFCLE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

CLE has a Return On Assets (0.61%) which is in line with its industry peers.
CLE's Return On Equity of 14.07% is fine compared to the rest of the industry. CLE outperforms 77.61% of its industry peers.
With a Return On Invested Capital value of 5.89%, CLE perfoms like the industry average, outperforming 56.72% of the companies in the same industry.
Industry RankSector Rank
ROA 0.61%
ROE 14.07%
ROIC 5.89%
ROA(3y)1.16%
ROA(5y)-2.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLE.MI Yearly ROA, ROE, ROICCLE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200

1.3 Margins

CLE's Profit Margin of 1.35% is in line compared to the rest of the industry. CLE outperforms 47.76% of its industry peers.
With a decent Operating Margin value of 9.00%, CLE is doing good in the industry, outperforming 67.16% of the companies in the same industry.
CLE's Gross Margin of 69.25% is fine compared to the rest of the industry. CLE outperforms 70.15% of its industry peers.
In the last couple of years the Gross Margin of CLE has grown nicely.
Industry RankSector Rank
OM 9%
PM (TTM) 1.35%
GM 69.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.27%
GM growth 5Y26.44%
CLE.MI Yearly Profit, Operating, Gross MarginsCLE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLE is creating some value.
The number of shares outstanding for CLE remains at a similar level compared to 1 year ago.
CLE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLE is higher compared to a year ago.
CLE.MI Yearly Shares OutstandingCLE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
CLE.MI Yearly Total Debt VS Total AssetsCLE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CLE has an Altman-Z score of -0.47. This is a bad value and indicates that CLE is not financially healthy and even has some risk of bankruptcy.
CLE has a worse Altman-Z score (-0.47) than 76.12% of its industry peers.
CLE has a Debt/Equity ratio of 5.17. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CLE (5.17) is worse than 80.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.17
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACC1.06
WACC5.58%
CLE.MI Yearly LT Debt VS Equity VS FCFCLE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

CLE has a Current Ratio of 0.71. This is a bad value and indicates that CLE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, CLE is doing worse than 74.63% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that CLE may have some problems paying its short term obligations.
With a Quick ratio value of 0.69, CLE is not doing good in the industry: 67.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69
CLE.MI Yearly Current Assets VS Current LiabilitesCLE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

CLE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.10%.
The Revenue has been growing slightly by 3.01% in the past year.
CLE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.19% yearly.
EPS 1Y (TTM)-94.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-964.29%
Revenue 1Y (TTM)3.01%
Revenue growth 3Y7.94%
Revenue growth 5Y2.19%
Sales Q2Q%-3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLE.MI Yearly Revenue VS EstimatesCLE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CLE.MI Yearly EPS VS EstimatesCLE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CLE.MI Price Earnings VS Forward Price EarningsCLE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLE is valued a bit cheaper than 79.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.45
CLE.MI Per share dataCLE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLASS EDITORI SPA

BIT:CLE (3/4/2025, 7:00:00 PM)

0.096

0 (-1.64%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners54.8%
Ins Owner ChangeN/A
Market Cap30.98M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF 10.94
P/B 4.24
P/tB N/A
EV/EBITDA 4.45
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY9.14%
SpS0.24
BVpS0.02
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 14.07%
ROCE 8.79%
ROIC 5.89%
ROICexc 6.11%
ROICexgc 45.76%
OM 9%
PM (TTM) 1.35%
GM 69.25%
FCFM N/A
ROA(3y)1.16%
ROA(5y)-2.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.27%
GM growth 5Y26.44%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 5.17
Debt/FCF N/A
Debt/EBITDA 2.68
Cap/Depr 76.17%
Cap/Sales 7.23%
Interest Coverage 250
Cash Conversion 20.05%
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z -0.47
F-Score6
WACC5.58%
ROIC/WACC1.06
Cap/Depr(3y)69.02%
Cap/Depr(5y)115.56%
Cap/Sales(3y)6.09%
Cap/Sales(5y)12.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-964.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.01%
Revenue growth 3Y7.94%
Revenue growth 5Y2.19%
Sales Q2Q%-3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-76.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2129.92%
OCF growth 3Y-20.31%
OCF growth 5Y142.15%